Medication Portability
Definition:
The degree to which a prescribed medication — particularly psychotropic and neurological medications such as stimulants, antidepressants, antipsychotics, and controlled analgesics — can be legally transported across national borders, prescribed, and dispensed in a host country. Medication portability is one of the most urgent practical challenges for internationally mobile neurodiverse and medically complex families, as the legal status of medications varies dramatically across jurisdictions, and medications that are standard prescription items in one country may be restricted, require special permits, or be entirely prohibited in another.
Comparable terms:
Prescription portability (HR/mobility, clinical — equivalent; broader; includes non-controlled medications) · Controlled substance regulations (see separate entry — the legal framework governing medication portability) · Medication continuity (clinical — the clinical goal of uninterrupted access to prescribed treatment) · Drug equivalency (pharmacological — the identification of equivalent medications available in the host country when the prescribed medication is unavailable)
Sources:
Stimulant ADHD medications including amphetamine-based drugs such as Adderall and methylphenidate-based options such as Ritalin and Concerta are among the most tightly controlled substances in international travel — banned outright in some countries including Japan and parts of the Middle East, and requiring detailed permits or paperwork in others — with consequences ranging from medication confiscation to detention and criminal charges. CHADD. (2022). Know before you go: International travel with ADHD medications. https://chadd.org/adhd-weekly/know-before-you-go-international-travel-with-adhd-medications/
The US State Department documents a case in which a US citizen was arrested in Japan after her prescribed stimulant medication was shipped to her there; Adderall, which is an amphetamine, is not legal in Japan; she was released after 18 days and significant legislative and diplomatic lobbying, illustrating that the risks of inadequate pre-departure medication planning are legal as well as medical.
See also:
Controlled Substance Regulations Abroad (Neurodiversity & Medical Complexity Abroad); EAP (Wellbeing & Mental Health); Global Mobility Policy (Professional Support Roles). Medication portability should be addressed in pre-departure planning as a mandatory item, not an afterthought. Global mobility specialists and HR professionals advising families with neurodiverse members on assignments to countries with restrictive medication regulations should treat this as a non-negotiable risk assessment step, equivalent to visa and tax equalization planning. The EAP entry describes the organizational support mechanism most likely to be called upon when medication access fails in the host country.
« Back